Home » Newsletters » BioWorld Science

BioWorld Science

April 20, 2000

View Archived Issues

Pharmacokinetics of SAM-486A useful in predicting toxicity

Positive preclinical results reported for Meditech's MTCH-24

Aurora Biosciences and Organon sign assay development agreement

Expired air from asthmatic subjects has unusually low pH

Initial clinical results with HE-2000 indicate immune system switch in HIV

Arisostatins identified as new tetrocarcin antibiotics with antibacterial/antitumor activity

Pharming highlights product development efforts for 1999

Clinical progress at Amylin during 1999 discussed

Adefovir dipivoxil shows activity against lamivudine-resistant HBV

Phytopharm invests in Indian manufacturing plant

Glaxo Wellcome obtains nonexclusive HCV license from Chiron

Company Profile: Novuspharma

New 5-HT4 antagonists preferably useful for urinary tract disorders

Antifungal lactone isolated from a fungus at Pfizer

SB's new dopamine D3 receptor modulators particularly useful for schizophrenia

Broad-spectrum carbapenems reported by Wyeth Lederle Japan

BioInvent to produce therapeutic antibody for Wilex

FDA approves Actonel for osteoporosis prevention and treatment

Flocor study results presented at sickle cell conference

BioTime begins clinical testing of new blood plasma volume expander

Major European launch announced for Sonata

Antihistamines reported useful by Schering-Plough for Rx of sinusitis and otitis media

Azabicyclic compounds as modulators of cell adhesion

Florida A&M's novel nonsteroidal antiinflammatory agents inhibit NO production

Preclinical and clinical efficacy of RWJ-270201 characterized at recent congress

FDA approves first oxazolidinone antimicrobial drug

PEG-hirudin superior to unfractionated heparin for short-term reduction of silent ischemia

Health Canada approves Aggrenox for prevention of recurrent stroke

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 27, 2026.
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
With improved technologies, biomarkers, failed drugs may come into their own
BioWorld
At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026